4.7 Article

Calreticulin levels determine onset of early muscle denervation by fast motoneurons of ALS model mice

Journal

NEUROBIOLOGY OF DISEASE
Volume 73, Issue -, Pages 130-136

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.nbd.2014.09.009

Keywords

Calreticulin; ALS; Muscle weakness and denervation; ER stress; mTOR

Categories

Funding

  1. Institut National de la Sante et de la Recherche Medicale (INSERM)
  2. Association Francaise contre les Myopathies (AFM) [15288/2011]
  3. Association Francaise pour la Recherche sur la SLA (ARSLA)
  4. European Union Mitotarget Consortium [FP7-223388]

Ask authors/readers for more resources

Although the precise signaling mechanisms underlying the vulnerability of some sub-populations of motoneurons in ALS remain unclear, critical factors such as metallo-proteinase 9 expression, neuronal activity and endoplasmic reticulum stress have been shown to be involved. In the context of SOD1(G93A) ALS mouse model, we previously showed that a two-fold decrease in calreticulin (CRT) is occurring in the vulnerable fast motoneurons. Here, we asked to which extent the decrease in CRT levels was causative to muscle denervation and/or motoneuron degeneration. Toward this goal, a hemizygous deletion of the crt gene in SOD1(G93A) mice was generated since the complete ablation of crt is embryonic lethal. We observed that SOD1(G93A);Crt(+/-) mice display increased and earlier muscle weakness and muscle denervation compared to SOD1(G93A) mice. While CRT reduction in motoneurons leads to a strong upregulation of two factors important in motoneuron dysfunction, ER stress and mTOR activation, it does not aggravate motoneuron death. Our results underline a prevalent role for CRT levels in the early phase of muscle denervation and support CRT regulation as a potential therapeutic approach. (C) 2015 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Biochemistry & Molecular Biology

Amyotrophic Lateral Sclerosis Genes in Drosophila melanogaster

Sophie Layalle, Laetitia They, Sarah Ourghani, Cedric Raoul, Laurent Soustelle

Summary: Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by the degeneration of motoneurons. Fruit flies have emerged as a versatile model for studying ALS, providing insights into cellular mechanisms and potential therapeutic targets for future treatments. Research on fruit fly ALS models has revealed novel pathogenic mechanisms and identified disease-modifying genes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Neurosciences

Dentate Granule Cells Recruited in the Home Environment Display Distinctive Properties

Claire Pleau, Angelique Peret, Edouard Pearlstein, Thomas Scalfati, Alexandre Vigier, Geoffrey Marti, Francois J. Michel, Thomas Marissal, Valerie Crepel

Summary: Research has found that DGCs recruited in the home cage condition are mature neurons with longer dendritic trees and lower excitability. The higher GABA(A) receptor-mediated shunting inhibition contributes to the lower excitability of DGCs activated in the home environment.

FRONTIERS IN CELLULAR NEUROSCIENCE (2021)

Article Biochemistry & Molecular Biology

Identification of secreted factors in dental pulp cell-conditioned medium optimized for neuronal growth

Batoul Chouaib, Pierre-Yves Collart-Dutilleul, Nicolas Blanc-Sylvestre, Richard Younes, Csilla Gergely, Cedric Raoul, Frederique Scamps, Frederic Cuisinier, Olivier Romieu

Summary: Stem cell-derived conditioned media show promise as pharmaceutical products for tissue regeneration, with human dental pulp cells (DPCs) conditioned medium enhancing neurite outgrowth in sensory neurons. Frozen storage does not affect activity, and 48 hours of conditioning is optimal. The addition of B-27 supplement enhances the regenerative effect of DPC secretome.

NEUROCHEMISTRY INTERNATIONAL (2021)

Review Clinical Neurology

An inventory of basic research in temporal lobe epilepsy

T. Marissal

Summary: Temporal lobe epilepsy is a severe neurological disease that affects up to 1% of adults, with roughly one third of patients being resistant to conventional pharmacological treatments. Surgical removal of the epileptic focus is often the last resort with no guarantee of symptom alleviation, highlighting the need for novel therapeutic approaches with limited side effects. Advances in understanding the cellular and molecular mechanisms of TLE are paving the way for new treatment perspectives.

REVUE NEUROLOGIQUE (2021)

Article Engineering, Biomedical

Whole and fractionated human platelet lysate biomaterials-based biotherapy induces strong neuroprotection in experimental models of amyotrophic lateral sclerosis

Flore Gouel, Kelly Timmerman, Philippe Gosset, Cedric Raoul, Mary Dutheil, Aurelie Jonneaux, Guillaume Garcon, Caroline Moreau, Veronique Danel-Brunaud, James Duce, Thierry Burnouf, Jean-Christophe Devedjian, David Devos

Summary: Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease with no cure. This study shows that heat-treated human platelet lysate may have neuroprotective effects in ALS models, suggesting it as a potential therapeutic approach.

BIOMATERIALS (2022)

Article Neurosciences

Astrocyte-targeting RNA interference against mutated superoxide dismutase 1 induces motoneuron plasticity and protects fast-fatigable motor units in a mouse model of amyotrophic lateral sclerosis

Cylia Rochat, Nathalie Bernard-Marissal, Emma Kaellstig, Sylvain Pradervand, Florence E. Perrin, Patrick Aebischer, Cedric Raoul, Bernard L. Schneider

Summary: This study evaluated the therapeutic potential of gene therapy targeting mutated SOD1 in mature astrocytes. The results showed that this treatment gradually restored neuromuscular connections and significantly improved neuromuscular function. Gene therapy in the spinal cord protected the most vulnerable fast-fatigable motor neurons, and specific muscle fiber types were also preserved.
Article Geriatrics & Gerontology

Muscle cells of sporadic amyotrophic lateral sclerosis patients secrete neurotoxic vesicles

Laura Le Gall, William J. Duddy, Cecile Martinat, Virginie Mariot, Owen Connolly, Vanessa Milla, Ekene Anakor, Zamalou G. Ouandaogo, Stephanie Millecamps, Jeanne Laine, Udaya Geetha Vijayakumar, Susan Knoblach, Cedric Raoul, Olivier Lucas, Jean Philippe Loeffler, Peter Bede, Anthony Behin, Helene Blasco, Gaelle Bruneteau, Maria Del Mar Amador, David Devos, Alexandre Henriques, Adele Hesters, Lucette Lacomblez, Pascal Laforet, Timothee Langlet, Pascal Leblanc, Nadine Le Forestier, Thierry Maisonobe, Vincent Meininger, Laura Robelin, Francois Salachas, Tanya Stojkovic, Giorgia Querin, Julie Dumonceaux, Gillian Butler Browne, Jose-Luis Gonzalez De Aguilar, Stephanie Duguez, Pierre Francois Pradat

Summary: Muscle vesicles may be a potential source of vesicle-mediated toxicity in ALS, as they are shown to be toxic to MNs.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2022)

Article Clinical Neurology

Imbalance of NRG1-ERBB2/3 signalling underlies altered myelination in Charcot-Marie-Tooth disease 4H

Lara El-Bazzal, Adeline Ghata, Clothilde Esteve, Jihane Gadacha, Patrice Quintana, Christel Castro, Nathalie Roeckel-Trevisiol, Frederique Lembo, Nicolas Lenfant, Andre Megarbane, Jean-Paul Borg, Nicolas Levy, Marc Bartoli, Yannick Poitelon, Pierre L. Roubertoux, Valerie Delague, Nathalie Bernard-Marissal

Summary: Charcot-Marie-Tooth (CMT) disease is a common inherited neurological disorder caused by mutations in over 100 genes. A study found that mutations in the FGD4 gene, which encodes FRABIN, can lead to aberrant myelination in the peripheral nervous system. The loss of FRABIN affects the NRG1/ERBB2/3 signaling pathway and impairs endocytic trafficking, contributing to myelination defects.

BRAIN (2023)

Article Multidisciplinary Sciences

Physiology of PNS axons relies on glycolytic metabolism in myelinating Schwann cells

Marie Deck, Gerben Van Hameren, Graham Campbell, Nathalie Bernard-Marissal, Jerome Devaux, Jade Berthelot, Alise Lattard, Jean-Jacques Medard, Benoit Gautier, Sophie Guelfi, Scarlette Abbou, Patrice Quintana, Juan Manuel Chao de la Barca, Pascal Reynier, Guy Lenaers, Roman Chrast, Nicolas Tricaud

Summary: Lactate production through PKM2 enzyme and aerobic glycolysis is essential for the long-term maintenance of peripheral nerve axon physiology and function.

PLOS ONE (2022)

Article Clinical Neurology

Comparison of spinal magnetic resonance imaging and classical clinical factors in predicting motor capacity in amyotrophic lateral sclerosis

M. Khamaysa, M. Lefort, M. Pelegrini-Issac, A. Lackmy-Vallee, A. Preuilh, D. Devos, A. -S. Rolland, C. Desnuelle, M. Chupin, V. Marchand-Pauvert, G. Querin, Pierre-Francois Pradat

Summary: This study aimed to evaluate the predictive value of cervical spinal cord MRI parameters for motor capacity in ALS compared to clinical prognostic factors. Structural MRI measurements were significantly correlated with the ALSFRS-R score and its sub-scores. Multiple linear regression models combining spinal multimodal MRI and clinical factors could predict motor capacity in ALS.

JOURNAL OF NEUROLOGY (2023)

Review Neurosciences

Early-onset, conjugal, twin-discordant, and clusters of sporadic ALS: Pathway to discovery of etiology via lifetime exposome research

Peter S. Spencer, Valerie S. Palmer, Glen E. Kisby, Emmeline Lagrange, B. Zane Horowitz, Raquel Valdes Angues, Jacques Reis, Jean-Paul Vernoux, Cedric Raoul, William Camu

Summary: The identity and role of environmental factors in sporadic amyotrophic lateral sclerosis (sALS) are not well understood, except for certain regions in the Western Pacific and French Alps. Exposure to DNA-damaging chemicals prior to the onset of motor neuron disease is strongly associated with ALS in these regions. This article discusses geographic clusters of ALS, familial cases, and young-onset cases in relation to their demographic and environmental associations, and highlights the importance of studying the lifetime exposome of young sALS cases for identifying ALS causation, mechanism, and prevention.

FRONTIERS IN NEUROSCIENCE (2023)

Article Biochemistry & Molecular Biology

The Secretome of Human Dental Pulp Stem Cells and Its Components GDF15 and HB-EGF Protect Amyotrophic Lateral Sclerosis Motoneurons against Death

Richard Younes, Youssef Issa, Nadia Jdaa, Batoul Chouaib, Veronique Brugioti, Desire Challuau, Cedric Raoul, Frederique Scamps, Frederic Cuisinier, Cecile Hilaire

Summary: The secretome of DPSCs contains neurotrophic factors that promote motoneuron survival and provide neuroprotective benefits to the ALS mouse model. The mechanisms of action and specific factors involved need further investigation. GDF15 and HB-EGF protect SOD1(G93A) motoneurons against nitric oxide-induced death, suggesting their potential therapeutic role in ALS.

BIOMEDICINES (2023)

Review Cell Biology

Cerebellar pathology in motor neuron disease: neuroplasticity and neurodegeneration

Rangariroyashe H. Chipika, Grainne Mulkerrin, Pierre-Francois Pradat, Aizuri Murad, Fabrice Ango, Cedric Raoul, Peter Bede

Summary: Amyotrophic lateral sclerosis (ALS) is a rapidly progressive multi-system disease, characterized by degeneration of upper and lower motor neurons. However, there is increasing recognition of extra-motor pathology, including cerebellar pathology. Cerebellar degeneration in ALS is often overlooked, but it contributes to a variety of clinical symptoms and has widespread connectivity to spinal and supratentorial regions.

NEURAL REGENERATION RESEARCH (2022)

Review Cell Biology

Cerebellar pathology in motor neuron disease: neuroplasticity and neurodegeneration

Rangariroyashe H. Chipika, Grainne Mulkerrin, Pierre-Francois Pradat, Aizuri Murad, Fabrice Ango, Cedric Raoul, Peter Bede

Summary: Amyotrophic lateral sclerosis is a multi-system disease characterized by degeneration of upper and lower motor neurons. Recent studies have shown that cerebellar pathology also plays a role in the disease. However, most research has focused on supratentorial disease, and there is a lack of post-mortem validation. Clinical symptoms of amyotrophic lateral sclerosis, such as dysarthria, dysphagia, cognitive and behavioral deficits, saccade abnormalities, gait impairment, respiratory weakness and pseudobulbar affect may be exacerbated by co-existing cerebellar pathology.

NEURAL REGENERATION RESEARCH (2022)

Review Clinical Neurology

Prionoids in amyotrophic lateral sclerosis

Philippe Gosset, William Camu, Cedric Raoul, Alexandre Mezghrani

Summary: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the loss of motoneurons in the brain and spinal cord. Disease onset is anatomically localized and progression occurs by spread to contiguous regions. This review discusses the relevance of prion-like propagation as a pathogenic determinant in disease progression.

BRAIN COMMUNICATIONS (2022)

Article Neurosciences

Cell-type brain-region specific changes in prefrontal cortex of a mouse model of alcohol dependence

Nihal A. Salem, Lawrence Manzano, Michael W. Keist, Olga Ponomareva, Amanda J. Roberts, Marisa Roberto, R. Dayne Mayfield

Summary: This study identified cell-type specific gene expression changes associated with alcohol dependence in the medial prefrontal cortex of mice. The results revealed dysregulated gene co-expression networks and differentially expressed genes in multiple cell types, highlighting the involvement of inhibitory neurons and astrocytes in alcohol dependence. Novel targets for studying molecular mechanisms contributing to alcohol dependence were also identified.

NEUROBIOLOGY OF DISEASE (2024)

Article Neurosciences

Sex-specific developmental alterations in DYRK1A expression in the brain of a Down syndrome mouse model

Laura E. Hawley, Megan Stringer, Abigail J. Deal, Andrew Folz, Charles R. Goodlett, Randall J. Roper

Summary: This study found that the overexpression of DYRK1A protein in Down syndrome mice varies with age, sex, and brain region, and reducing the copy number of Dyrk1a can decrease the expression of DYRK1A. These sex-specific patterns of DYRK1A overexpression may provide mechanistic targets for therapeutic intervention in Down syndrome.

NEUROBIOLOGY OF DISEASE (2024)